Breckenridge Pharmaceutical, Inc. News
Breckenridge Announces Approval of Generic Activella(R)
Estradiol/Norethindrone Acetate Tablets are AB rated to Activella(R), a brand product marketed by Novo Nordisk(R), which is used as a treatment for moderate to severe vasomotor symptoms associated with menopause, and as prevention for postmenopausal osteoporosis.
The brand product had trailing 12 month sales of
Breckenridge is actively seeking development and marketing alliances with domestic and foreign companies for generic and branded pharmaceuticals.
Breckenridge products are contract manufactured through partnerships with pharmaceutical manufacturers in state-of-the-art facilities throughout the world. Breckenridge maintains a stringent Quality Assurance program to ensure a consistent supply of quality pharmaceutical products.
About Breckenridge:
Breckenridge Pharmaceutical, Inc., a privately-held pharmaceutical marketing research and development company founded in 1983, is headquartered in
Activella(R) is a registered trademark of Novo Nordisk FemCare AG.
Novo Nordisk(R) is a registered trademark of Novo Nordisk A/S Corporation.
SOURCE Breckenridge Pharmaceutical, Inc.
Search Our News Using Google Search
Can't find what you want? Try using Google:
